 |
Vol.48 No.6 contents | Japanese/English |
 | Full Text of PDF (531K) Article in Japanese |
- The 22nd Lung Cancer Workshop -
The Results of a Case Control Study of Gefitinib
Takeshi Johkoh11Department of Radiology, Kinki Central Hospital of Mutual Aid Association of Public School Teachers, Japan
A case control study of gefitinib showed the following 3 important points. 1. Accompanying chronic interstitial pneumonia is a risk factor for higher frequency of drug induced lung diseases and poor prognosis. 2. Decreased amount of normal lung before treatment is also a risk factor for the frequency of drug induced lung diseases and poor prognosis. 3. Increased amount of the areas where respiratory movement is restricted due to adhesion improves prognosis.
key words: Drug induced lung disease, Gefitinib, CT, Chronic interstitial pneumonia, Acute exacerbation
JJLC 48 (6): 727-731, 2008
